drugset / Trial / NCT07123402
To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia
Phase 2
Enrolling by invitation
184 enrolled
Beijing Tide Pharmaceutical Co., Ltd
China-Japan Friendship Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase II, multicenter ,randomized, double-blind, placebo-controlled, dose-finding study designed to evaluate the efficacy and safety of TRD205 tablets in the treatment of chronic postoperative neuralgia
Timeline
- Start
- 2025-04-09
- Primary completion
- 2026-04-20
- Completion
- 2026-05-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TRD205 | Unknown | 200 mg | Oral |
| Subject | TRD205 | Unknown | 400 mg | Oral |
| Subject | TRD205 | Unknown | 600 mg | Oral |